LOVE vs SRPT · P/E 56, rev $697.1M vs rev $1.13B
The Lovesac Company (LOVE) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
The Lovesac Company (LOVE) is a furnishings, fixtures & appliances company listed on NASDAQ.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported LOVE revenue for 2026-02-01 was $697.1M. Net income was $4.1M. Revenue was up 2.4% from 2025-02-02 to 2026-02-01. LOVE currently screens at market cap $205.4M and trailing P/E 56.1.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
LOVE currently screens at market cap $205.4M and trailing P/E 56.1. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the LOVE and SRPT stock pages for the full models.
Not investment advice.